AML digital therapeutic lands Breakthrough Device Designation from FDA
Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.
Archives for January 17, 2022
Vanderbilt discovery offers hope for colorectal cancer patients
The researchers, in studying how polyps morph into colorectal cancer, have set a path for improved surveillance of the disease, harnessing precision medicine.